• Aucun résultat trouvé

SYLVESTRE, CAMILLE

Dans le document R A P P O R T A N N U E L (Page 105-108)

BOURSES, SUBVENTIONS DE RECHERCHE ET PROJETS

SYLVESTRE, CAMILLE

 Shaulov T, Sierra S, Sylvestre C. Recurrent implantation failure in IVF: A Canadian Fertility and Andrology Society Clinical Practice Guideline.

Reprod Biomed Online. 2020 Aug 20:S1472-6483(20)30440-5

 Préaubert L, Shaulov T, Phillips S, Stutz M, Kadoch IJ, Sylvestre C, Lehmann P. Live birth rates remain stable in modified natural IVF despite low anti-Mullerian hormone: analysis of 638 cycles. Repro BioMed Online September 2019; 39(3);461-66

TAILLEFER, CATHERINE

Taillefer C. Étiologies maternelles de la MIU. 9e Congrès annuel du Gémoq, L’Estérel, Québec.

Taillefer C. Prise en charge obstétricale et psychologique de la MIU.

Formation prénatale, AOGQ, Montréal, Québec

Taillefer C. Mesurer les pertes sanguines menstruelles et post-partum: les défis. 1ère Journée d’Hémostase au Féminin, CHU Sainte-Justine, Montréal, Québec

 Zerounian S, Wavrant S, David M, Codsi E, Delrue M, Taillefer C. Antenatal diagnosis of Blackfan-Diamond anemia. Affiche présentée au 15th ISUOG International Symposium, Berlin, Allemagne

105 WAGNER, MARIE-SOLEIL

 Devane C, Renner R, Munro S, Guilbert E, Dunn S, Wagner MS, Norman WV. Implementation of mifepristone medical abortion in Canada: Pilot and Feasibility Testing of a Survey to Assess Facilitators and Barriers.

Soumis pour publication Pilot and Feasibility Studies 2019;5:126

Wagner MS, Munro S, Wilcox ES, Devane C, Norman WV, Dunn S, Soon JA, Guilbert E. Barriers and Facilitators to the Implementation of first Trimester Medical Abortion With Mifepristone in the Province of Québec:

A Qualitative Investigation. Journal of Obstetrics and Gynaecology Canada. 2020; DOI: https://doi.org/10.1016/j.jogc.2019.10.037

 Guilbert E, Wagner MS, Munro S, Wilcox ES, Dunn S, Soon JA, Devane C, Norman WV. Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation. The European Journal of Contraception & Reproductive Health Care. 2020.

DOI: 10.1080/13625187.2020.1743825

 Munro S, Guilbert E, Wagner MS, Wilcox E, Devane C, Dunn S, Brooks M, Soon JA, Mills M, Leduc-Robert G, Wahl K, Zannier E, Norman WV. Factors influencing implementation of mifepristone medical abortion among Canadian physicians: a national qualitative study. Accepté pour publication Annals of Family Medicine

 Guilbert E, Wagner MS, Munro S, Wilcox ES, Devane C, Dunn S, Soon J, Norman, WV. (2019). La pilule abortive au Québec en 2019 – Pourquoi n’est-elle pas plus accessible? Rapport de recherche de la CART-MIFE-Study.Québec;107p.

 Costescu D, Guilbert E, Wagner MS, Dunn S, Norman WV, Black A, Renner R, Bernardin J, Fitzsimmons, Trouton K. Induced Abortion: Updated Guidance during Pandemic and Periods of Social Disruption. 2020 (6 pages)

 Costescu D, Guilbert E, Wagner MS, Dunn S, Norman WV, Black A, Renner R, Bernardin J, Fitzsimmons, Trouton K. Avortement provoqué : Mise à jour des lignes directrices en cas de pandémie et de périodes de bouleversements sociaux. 2020 (8 pages)

 Guilbert E, Costescu D, Wagner MS, RennerR, Norman WV, Dunn S, Fitzsimmons, et al. Canadian Protocol for the Provision of Medical Abortion via Telemedicine. 2020 (5 pages)

 Guilbert E, Costescu D, Wagner MS, RennerR, Norman WV, Dunn S, Fitzsimmons, et al. Protocole canadien de prestation de l’avortement médical par télémédecine. 2020 (5 pages)

 Black A, Costescu D, Guilbert E, Dunn S, Norman WV, Trouton K, Todd N, Wagner MS, et al. Contraception Consensus: Updated Guidance during Pandemic and Periods of Social Disruption. 2020 (9 pages)

 Black A, Costescu D, Guilbert E, Dunn S, Norman WV, Trouton K, Todd N, Wagner MS, et al. Consensus sur la contraception : Mise à jour des lignes directrices en cas de pandémie et de périodes de bouleversements sociaux. 2020 (11 pages)

 Dunn S, Devane C, Munro S, Soon J, Guilbert E, Wagner MS, Norman WV.

Supporting implementation of mifepristone abortion in Canada: A mixed methods study of the CAPS community of practice. Contraception 2019;100(4):323

Wagner MS. Avortement médical au 2e trimestre. Conférencière invitée au Congrès annuel de l’Association des obstétriciens et gynécologues du Québec (AOGQ), Chicoutimi, Québec, Canada. 1er juin 2019

Wagner MS, Guilbert E. La contraception en cas de pandémie et de périodes de bouleversements sociaux. Présentation scientifique sous forme d’affiche au forum en ligne à la Société des obstétriciens et gynécologues du Canada (SOGC). 6 mai 2020

 Dunn S, Devane C, Munro S, Soon JA, Guilbert E, Wagner MS, Norman WV. Supporting implementation of mifepristone abortion in Canada: A mixed methods study of the CAPS Community of Practice. North American Forum on Family Planning. Los Angeles (CA), États-Unis. 19-21 octobre 2019

 Dunn S, Norman W, Martin-Misener R, Munro S, Guilbert E. Wagner MS, Norman WV. Supporting implementation of mifepristone abortion in Canada: A mixed methods study of a virtual community of practice. North American Primary Care Research Group (NAPCRG) Annual Meeting.

Toronto (ON), Canada. 16-20 novembre 2019 WAVRANT, SANDRINE

 Sommer J, Nuyt Am, Audibert F, Dorval V, Wavrant S, Lapointe A, Altit G.

Renal functional markers in extremely premature infants with and without twin twin transfusion syndrome. J perinatol. 2020 feb;40(2)

106

 Zerounian S, Wavrant S, David M, Codsi E, Delrue MA, Taillefer C.

Antenatal diagnosis of Diamond-Blackfan anemia. 29rd World Congress on Ultrasound in Obstetrics and Gynecology, Berlin (Deutschland), oct 2019

 Zerounian S, Codsi E, Delrue MA, Rypens F, Wavrant S. Antenatal diagnosis of congenital lymphoedema. 29rd World Congress on Ultrasound in Obstetrics and Gynecology, Berlin (Deutschland), oct 2019

 Zerounian S, Delrue MA, Rypens F, Codsi E, Wavrant S. Early diagnosis of Nager syndrome in dichorionic twins. 29rd World Congress on Ultrasound in Obstetrics and Gynecology, Berlin (Deutschland), oct 2019

 Carmant L, Wavrant S, Codsi E. Expectant Management of Monochorionic Triamniotic Triplets Complicated by Selective in Utero Growth Restriction:

Report of 2 Cases. 29rd World Congress on Ultrasound in Obstetrics and Gynecology, Berlin (Deutschland), oct 2019

 Carmant L, Audibert F, Wavrant S, Codsi E. Impact of Selective Intrauterine Growth Restriction on Laser Therapy Outcomes in Twin Twin Transfusion Syndrome. SMFM, Grapevine (USA), feb 2020

 Carmant L, Zerounian S, Boucoiran I, Wavrant S. Pericardiocentesis in severe isolated pericardial effusion: a case report. 30rd World Congress on Ultrasound in Obstetrics and Gynecology, Glasgow (Scotland), oct 2020

 Carmant L, Dorey M, Boutin C, Codsi E, Wavrant S. Management of supraventricular tachycardia diagnosed at 12 weeks: a case report. 30rd World Congress on Ultrasound in Obstetrics and Gynecology, Glasgow (Scotland), oct 2020

 Codsi E, Carmant L, Wavrant S, Delrue MA. Cell Free DNA Knowledge of the Generalist Obstetricians: A Transversal Study. 30rd World Congress

on Ultrasound in Obstetrics and Gynecology, Glasgow (Scotland), oct 2020

WO, BI LAN

 Campo MA, Phamphile JC, Grand'Maison S, Wo BL,Tardif ML, Sauvé N and Mahone M. Is management of mild intrahepatic cholestasis of pregnancy associated with maternal and fetal complications? Présentation orale à la NASOM Annual Conference. Vancouver, Canada. Mars 2019

 Goyette F, Wo BL, Iglesias MH, Rey E and Godbout A. One-Step versus Two Step Approach for Gestational Diabetes Mellitus Screening:

Comparison of Maternal and Fetal Outcomes in a Canadian population.

Présentation orale à l’Endocrine Society annual meeting. San Francisco, États-Unis. Mars 2020

107 REMERCIEMENTS

ACTIVITÉS D’ENSEIGNEMENT

Dans le document R A P P O R T A N N U E L (Page 105-108)

Documents relatifs